Well Lead Medical Co., Ltd. (SHA:603309)

Market Cap	4.12B +13.5%
Revenue (ttm)	1.64B +11.5%
Net Income	244.31M +13.5%
EPS	0.83 +12.1%
Shares Out	291.87M
PE Ratio	17.01
Forward PE	13.64
Dividend	0.40 (2.85%)
Ex-Dividend Date	Jan 8, 2026

Volume	3,651,850
Average Volume	5,704,930
Open	14.08
Previous Close	14.03
Day's Range	13.81 - 14.18
52-Week Range	10.60 - 16.42
Beta	-0.09
RSI	42.55
Earnings Date	Apr 23, 2026

About Well Lead Medical

Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in urology, endourology, anaesthesia, respiratory, hemodialysis, and pain management areas worldwide. It provides urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guide wires, ureteral stent, urethral and ureteral dilation, and stone retrieval basket; anesthesia products, comprising endotracheal tubes, intubation acc...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1998
• Employees: 2,622
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603309

Financial Performance

In 2024, Well Lead Medical's revenue was 1.51 billion, an increase of 8.76% compared to the previous year's 1.39 billion. Earnings were 219.39 million, an increase of 13.98%.